메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Shanjie Wang (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Kegong Chen (Department of Thoracic Surgery First Affiliated Hospital of Anhui Medical University) Ye Wang (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Zeng Wang (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Zhaoying Li (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) JunChen Guo (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Jianfeng Chen (Laboratory Animal Center Second Affiliated Hospital of Harbin Medical University) Wenhua Liu (Department of Intensive Care Medicine Second Affiliated Hospital of Harbin Medical University) Xiaohui Guo (Department of Pathology First Affiliated Hospital of Anhui Medical University) Guangcan Yan (Department of Epidemiology and Biostatistics School of Public Health Harbin Medical University) Chenchen Liang (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Huai Yu (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Shaohong Fang (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil) Bo Yu (The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Heilongjiang Key Laboratory for Accurate Diagnosis and Treatment of Coronary Heart Disease Department of Cardiology Second Affil)
저널정보
한국생체재료학회 생체재료학회지 생체재료학회지 제27권
발행연도
2023.3
수록면
1,146 - 1,162 (17page)
DOI
https://doi.org/10.1186/s40824-023-00377-8

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background Large-dose melatonin treatment in animal experiments was hardly translated into humans, which may explain the dilemma that the protective effects against myocardial injury in animal have been challenged by clinical trials. Ultrasound-targeted microbubble destruction (UTMD) has been considered a promising drug and gene delivery system to the target tissue. We aim to investigate whether cardiac gene delivery of melatonin receptor mediated by UTMD technology optimizes the efficacy of clinically equivalent dose of melatonin in sepsis-induced cardiomyopathy. Methods Melatonin and cardiac melatonin receptors in patients and rat models with lipopolysaccharide (LPS)- or cecal ligation and puncture (CLP)-induced sepsis were assessed. Rats received UTMD-mediated cardiac delivery of RORα/cationic microbubbles (CMBs) at 1, 3 and 5 days before CLP surgery. Echocardiography, histopathology and oxylipin metabolomics were assessed at 16–20 h after inducing fatal sepsis. Results We observed that patients with sepsis have lower serum melatonin than healthy controls, which was observed in the blood and hearts of Sprague–Dawley rat models with LPS- or CLP-induced sepsis. Notably, a mild dose (2.5 mg/kg) of intravenous melatonin did not substantially improve septic cardiomyopathy. We found decreased nuclear receptors RORα, not melatonin receptors MT1/2, under lethal sepsis that may weaken the potential benefits of a mild dose of melatonin treatment. In vivo, repeated UTMD-mediated cardiac delivery of RORα/CMBs exhibited favorable biosafety, efficiency and specificity, significantly strengthening the effects of a safe dose of melatonin on heart dysfunction and myocardial injury in septic rats. The cardiac delivery of RORα by UTMD technology and melatonin treatment improved mitochondrial dysfunction and oxylipin profiles, although there was no significant influence on systemic inflammation. Conclusions These findings provide new insights to explain the suboptimal effect of melatonin use in clinic and potential solutions to overcome the challenges. UTMD technology may be a promisingly interdisciplinary pattern against sepsis-induced cardiomyopathy.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0